4//SEC Filing
Herrmann John A III 4
Accession 0001209191-23-017583
CIK 0001000694other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:00 PM ET
Size
8.3 KB
Accession
0001209191-23-017583
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Herrmann John A III
SVP, General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-03-07+44,280→ 44,280 totalExercise: $6.97From: 2024-03-07Exp: 2033-03-07→ Common Stock (44,280 underlying) - Award
Restricted Stock Units
2023-03-07+38,330→ 38,330 total→ Common Stock (38,330 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 7, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001610928
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:00 PM ET
- Size
- 8.3 KB